Health Canada inspection
WuXi Advanced Therapies, Inc.: Health Canada inspection of Mar 11, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | WuXi Advanced Therapies, Inc. |
|---|---|
| City | Philadelphia |
| Province | PA |
| Country | United States |
| Program | GMP |
| Start date | Mar 8, 2022 |
| End date | Mar 11, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.